1.Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W, Practice Guidelines Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.
2.North Italian Endoscopic Club for the S, Treatment of Esophageal V. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The New England journal of medicine. 1988;319(15):983–9.
3.de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clinics in liver disease. 2001;5(3):645–63.
4.Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997;25(2):307–12.
5.Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16(6):1343–9.
6.Haq I, Tripathi D. Recent advances in the management of variceal bleeding. Gastroenterology report. 2017;5(2):113–26.
7.Laimer M, Pohla-Gubo G, Diem A, Prodinger C, Bauer JW, Hintner H. Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network: Example of a centre of expertise implemented in a European reference network to face the burden of a rare disease. Wiener klinische Wochenschrift. 2017;129(1–2):1–7.
8.Sarin SK, Kumar A. Endoscopic treatment of gastric varices. Clinics in liver disease. 2014;18(4):809–27.
9.Mansour L, El-Kalla F, El-Bassat H, Abd-Elsalam S, El-Bedewy M, Kobtan A, et al. Randomized controlled trial of scleroligation versus band ligation alone for eradication of gastroesophageal varices. Gastrointestinal endoscopy. 2017;86(2):307–15.
10.Sarin SK, Kumar A, Angus PW, Baijal SS, Baik SK, Bayraktar Y, et al. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatology international. 2011;5(2):607–24.
11.de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. Journal of hepatology. 2015;63(3):743–52.
12.Terg R, Gadano A, Cartier M, Casciato P, Lucero R, Munoz A, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver international: official journal of the International Association for the Study of the Liver. 2009;29(3):415–9.
13.Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71.
14.Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652–60.
15.Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146(2):412–19 e3.
16.Seo YS. Prevention and management of gastroesophageal varices. Clinical and molecular hepatology. 2018;24(1):20–42.
17.Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60(3):954–63.
18.Bosch J. Prevention of variceal rebleeding: endoscopes, drugs, and more. Hepatology. 2000;32(3):660–2.
19.Sung JJ, Tsoi KK, Lai LH, Wu JC, Lau JY. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007;56(10):1364–73.
20.Dong XJ, Chen WQ. [Therapeutic efficacy of endoscopic variceal ligation to treat gastric varices: a study of 63 consecutive cases]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2013;21(9):692–6.
21.Xu L, Ji F, Xu QW, Zhang MQ. Risk factors for predicting early variceal rebleeding after endoscopic variceal ligation. World journal of gastroenterology. 2011;17(28):3347–52.
22.Kim SJ, Choi CW, Kang DH, Kim HW, Park SB, Hong YM, et al. Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding. Clinical and molecular hepatology. 2016;22(4):466–76.
23.Kang EJ, Jeong SW, Jang JY, Cho JY, Lee SH, Kim HG, et al. Long-term result of endoscopic Histoacryl (N-butyl–2-cyanoacrylate) injection for treatment of gastric varices. World journal of gastroenterology. 2011;17(11):1494–500.
24.Jun CH, Kim KR, Yoon JH, Koh HR, Choi WS, Cho KM, et al. Clinical outcomes of gastric variceal obliteration using N-butyl–2-cyanoacrylate in patients with acute gastric variceal hemorrhage. The Korean journal of internal medicine. 2014;29(4):437–44.
25.Mishra SR, Sharma BC, Kumar A, Sarin SK. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. Journal of hepatology. 2011;54(6):1161–7.
26.Chen WT, Lin CY, Sheen IS, Huang CW, Lin TN, Lin CJ, et al. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World journal of gastroenterology. 2011;17(16):2120–5.
27.Elalfy H, Elsherbiny W, Abdel Rahman A, Elhammady D, Shaltout SW, Elsamanoudy AZ, et al. Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients. World journal of hepatology. 2016;8(24):1028–37.
28.Ying L, Lin X, Xie ZL, Hu YP, Shi KQ. Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Digestive diseases and sciences. 2012;57(6):1672–81.